Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:43 PM
Ignite Modification Date:
2025-12-26 @ 10:43 PM
NCT ID:
NCT02557412
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of dyslipidemia: The existence of a previous clinical diagnostic of dyslipidemia associated with lipid-lowering therapy. It is also considered patients who have an altered analytical, using the following cutoffs: total cholesterol ≥ 200 mg / dl, triglycerides ≥ 180 mg / dl, HDL-cholesterol ≤ 40 mg / dl or LDL-cholesterol ≥ 150 mg / dl. Lipid-lowering treatment and diet, stable in the last month.
* A concentration of LDL-cholesterol above 100 mg / dl, in the month prior to inclusion.
* An apnea-hypopnea index between 5-30 h-1
Exclusion Criteria:
* Apnea-hypopnea index of less than 5 h-1 or greater than 30 h-1.
* Predominance of central apneas and hypopneas, defined as more than 25% of all respiratory events.
* Professional drivers, risk profession or respiratory failure (according to criteria of the clinical pathway for diagnosis and treatment of sleep-disordered breathing).
* Very excessive daytime sleepiness (Epworth Sleepiness Scale\> 18).
* Morbid obesity (BMI\> 40 kg / m2).
* Prior treatment with CPAP.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
35 Years
Maximum Age:
75 Years
Study:
NCT02557412
Study Brief:
Protocol Section:
NCT02557412